drugset / Trial / NCT00415766

Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders

NCT00415766 ↗

Phase 4 Unknown 150 enrolled Eugonia
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.

Timeline

Start
2013-06
Primary completion
2015-12
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator rHCG Protein / enzyme biologic 250 ug Subcutaneous
Comparator uHCG Protein / enzyme biologic 5000 iu —
Comparator uHCG Protein / enzyme biologic 7500 iu —

Indications